Document Detail


Maternal omega-3 fatty acid supplementation and risk for perinatal maternal depression.
MedLine Citation:
PMID:  20925595     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: A systematic review was conducted to assess the possible association between omega-3 polyunsaturated fatty acid (PUFA) supplementation and intake in the perinatal period and the risk of maternal perinatal depression.
METHODS: Two PubMed searches and a BIOSIS Preview, a Web of Science and a PsychInfo search were conducted with the search terms 'DHA, pregnancy and depression' and 'omega-3 fatty acids, pregnancy and depression'.
RESULTS: Ten articles - three longitudinal cohort studies, five randomized controlled trials and two pilot trials- that met selection criteria were reviewed. Six found no association, two found mixed results, and two found a positive association between omega-3 PUFAs and reduced incidence of maternal perinatal depression. The heterogeneity of results can be explained by dissimilar study designs, including differences in study duration, time period of measurement and number of participants, and in varied dosages and types of supplemental PUFAs. Some of the larger studies and those that found a positive effect were more likely to be using higher doses, close to 2 g of docosahexaeonic acid (DHA) + eicosapentaenoic acid (EPA), and began the supplementation earlier in pregnancy.
CONCLUSIONS: Future RCTs to investigate the role of PUFA supplementation and risk for maternal perinatal depression should begin supplementation early in pregnancy and use a dosage closer to 2 g of DHA + EPA. Depression should also be measured using a diagnostic interview schedule in addition to a screener.
Authors:
Janet M Wojcicki; Melvin B Heyman
Related Documents :
19546565 - Prenatal stress and neurodevelopment of the child: focus on the hpa axis and role of th...
19909665 - Pregnancy and depression: exploring a new potential treatment option.
9741675 - Prenatal stress alters brain biogenic amine levels in primates.
10856475 - Psychological status of in vitro fertilization patients during pregnancy: a longitudina...
10073905 - Prenatal genotyping of the duffy blood group system by allele-specific polymerase chain...
7450565 - Humoral endorphin in human body fluids during pregnancy.
Publication Detail:
Type:  Journal Article; Review     Date:  2010-10-07
Journal Detail:
Title:  The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians     Volume:  24     ISSN:  1476-4954     ISO Abbreviation:  J. Matern. Fetal. Neonatal. Med.     Publication Date:  2011 May 
Date Detail:
Created Date:  2011-04-11     Completed Date:  2011-08-08     Revised Date:  2012-05-10    
Medline Journal Info:
Nlm Unique ID:  101136916     Medline TA:  J Matern Fetal Neonatal Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  680-6     Citation Subset:  IM    
Affiliation:
Department of Pediatrics, University of California, San Francisco, CA, USA. wojcickij@peds.ucsf.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Depression, Postpartum / prevention & control*
Dietary Supplements
Docosahexaenoic Acids / administration & dosage*
Eicosapentaenoic Acid / administration & dosage*
Female
Humans
Longitudinal Studies
Pregnancy
Randomized Controlled Trials as Topic
Risk
Grant Support
ID/Acronym/Agency:
K01 DK080825/DK/NIDDK NIH HHS; K01 DK080825-03/DK/NIDDK NIH HHS
Chemical
Reg. No./Substance:
1553-41-9/Eicosapentaenoic Acid; 25167-62-8/Docosahexaenoic Acids
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  K(ATP) channels process nucleotide signals in muscle thermogenic response.
Next Document:  Anti-IL-17A therapy protects against bone erosion in experimental models of rheumatoid arthritis.